| CAS ID: | 298680-25-8 |
| Molecular Formula: | C26H31N5O4 |
| Molecular Weight: | 477.6 g/mol |
| Monoisotopic Mass: | 477.238 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | RPL-554 |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C26H31N5O4/c1-15-10-16(2)24(17(3)11-15)29-23-14-20-19-13-22(35-5)21(34-4)12-18(19)6-8-30(20)26(33)31(23)9-7-28-25(27)32/h10-14H,6-9H2,1-5H3,(H3,27,28,32) | See All |
| InChI Key: | CSOBIBXVIYAXFM-UHFFFAOYSA-N | |
| Smiles: | CC1=CC(=C(C(=C1)C)N=C2C=C3C4=CC(=C(C=C4CCN3C(=O)N2CCNC(=O)N)OC)OC)C | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT02919995 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | September 30, 2016 | Last Verified | March 20, 2019 |
| Sponsor | Verona Pharma plc | ||
| PubChem: | 9934746 |
| ChEMBL: |